IMMU-22. PHARMACOLOGICALLY TARGETING EXTRACELLULAR VESICLE-IMMUNE CELL INTERACTIONS IN GLIOBLASTOMA

Glioblastoma (GBM) is the most aggressive type of primary brain cancer and carries a dire prognosis. Increasing evidence points to extracellular vesicles (EVs) as a means by which GBM tumor cells modulate the tumor microenvironment, leading to immunosuppression and disease progression. Several pharm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Himes, Benjamin, Fain, Cori, Tritz, Zachariah, Parney, Ian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217289/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.525
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg